Insiders who reported open-market trades in the last 12 months at the companies Jonathan Allan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Adrian R. Krainer - $3.90M in STOK purchases and sales in the last 12 months
Barry Ticho - $1.88M in STOK purchases and sales in the last 12 months
Edward M. Md Kaye - $934K in STOK purchases and sales in the last 12 months
Arthur Tzianabos - $174K in STOK purchases and sales in the last 12 months
Thomas Leggett - $147K in STOK purchases and sales in the last 12 months
Jason Hoitt - $119K in STOK purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Jonathan Allan is a corporate insider, tracked as GENERAL COUNSEL & CORP SEC of Stoke Therapeutics, Inc. (STOK). InsiderAlpha holds 18 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jonathan Allan submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Jonathan Allan been buying or selling stock?
Recorded transactions: 0 open-market purchases and 29 open-market sales ($2.44M) across all tracked filings.
Jonathan Allan is GENERAL COUNSEL & CORP SEC of Stoke Therapeutics, Inc. (STOK). 18 SEC Form 4 filings on record going back to 2024, most recently on 2 October 2026. Most recent open-market trade: sold $17K of STOK on 2 October 2026. Lifetime open-market sales: $2.44M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Jonathan Allan.
InsiderAlpha's records for Jonathan Allan go back to 2024: 18 primary Form 4 filings, an average of 6.0 per year. 16 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
